Stoichiometric selection of tight-binding inhibitors by wild-type and mutant forms of malarial (Plasmodium falciparum) dihydrofolate reductase

被引:19
作者
Kamchonwongpaisan, S
Vanichtanankul, J
Tarnchompoo, B
Yuvaniyama, J
Taweechai, S
Yuthavong, Y
机构
[1] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol, Pathum Thani 12120, Thailand
[2] Mahidol Univ, Ctr Excellence Prot Struct & Funct, Bangkok 10400, Thailand
[3] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 10400, Thailand
关键词
D O I
10.1021/ac0487597
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A simple method for screening combinatorial and other libraries of inhibitors of malarial (Plasmodium falciparum) dihydrofolate reductase (PfDHFR) has been developed, based on the affinities of the inhibitors with the enzyme. In the presence of limiting amounts of the enzyme, a number of inhibitors in the library were bound to extents reflecting the relative binding affinities. Following ultrafiltration and guanidine hydrochloride treatment to release bound inhibitors, the amounts of free and bound inhibitors could be determined by high-performance liquid chromatography and liquid chromatography-mass spectrometry. The differences in the patterns reflected the binding of high-affinity components compared with the other members in the library. A good correlation was found between the inhibition constants (K-i values) and the extent of binding of inhibitors to wild-type, double (C59R+S108N) and quadruple mutant (N511+ C59R+S108N+I164L) of PfDHFR, as well as human DHFR. In addition to identifying lead components of the libraries with high affinities (low K-i values) and stabilities (low k(off) rates), this simple method also provides an alternative way for quickly and accurately calculating enzyme binding affinities of inhibitors in combinatorial chemical libraries.
引用
收藏
页码:1222 / 1227
页数:6
相关论文
共 16 条
  • [1] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [2] Breman JG, 2001, AM J TROP MED HYG, V64, P1
  • [3] Mechanisms of resistance of Plasmodium falciparum to antimalarial drugs
    Hyde, JE
    [J]. MICROBES AND INFECTION, 2002, 4 (02) : 165 - 174
  • [4] Inhibitors of multiple mutants of Plasmodium falciparum dihydrofolate reductase and their antimalarial activities
    Kamchonwongpaisan, S
    Quarrell, R
    Charoensetakul, N
    Ponsinet, R
    Vilaivan, T
    Vanichtanankul, J
    Tarnchompoo, B
    Sirawaraporn, W
    Lowe, G
    Yuthavong, Y
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (03) : 673 - 680
  • [5] Combinatorial mixture synthesis and biological evaluation of dihydrophenyl triazine antifolates
    Lee, HK
    Chui, WK
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (06) : 1255 - 1262
  • [6] Rational drug design approach for overcoming drug resistance: Application to pyrimethamine resistance in malaria
    McKie, JH
    Douglas, KT
    Chan, C
    Roser, SA
    Yates, R
    Read, M
    Hyde, JE
    Dascombe, MJ
    Yuthavong, Y
    Sirawaraporn, W
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (09) : 1367 - 1370
  • [7] Nikolic D, 1998, COMB CHEM HIGH T SCR, V1, P47
  • [8] Sirawaraporn W, 1997, P NATL ACAD SCI USA, V94, P1124, DOI 10.1073/pnas.94.4.1124
  • [9] Snow RW, 1999, B WORLD HEALTH ORGAN, V77, P624
  • [10] Development of 2,4-diaminopyrimidines as antimalarials based on inhibition of the S108N and C59R+S108N mutants of dihydrofolate reductase from pyrimethamine-resistant Plasmodium falciparum
    Tarnchompoo, B
    Sirichaiwat, C
    Phupong, W
    Intaraudom, C
    Sirawaraporn, W
    Kamchonwongpaison, S
    Vanichtanankul, J
    Thebtaranonth, Y
    Yuthavong, Y
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (06) : 1244 - 1252